Clinical Trial Update: A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas [Phase 1]

View source ↗

Summary

This clinical trial update reports that ATG-031 is being studied in a Phase 1 trial for patients with advanced solid tumors or B-cell non-Hodgkin lymphoma, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• ATG-031

Snippet

Sponsor: Antengene Biologics Limited | Conditions: Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas | Phase 1 | Status: RECRUITING